TMED vs ARKG
5YT. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care ETF · $35MARK Genomic Revolution ETF · $2.2B
[…]3 years · per year[…] · $19,831+25.6%
[…]5 years · per year[…] · $6,267−8.9%
0.44%Expense ratio$44 · $75 on $10k · lower wins0.75%
0.46%12-mo yield$46 · $0 on $10k0.00%
−11.1%Worst dropSmaller wins−27.5%
19.6%VolatilityLower wins47.0%
4–0TMED wins
$10,000 · 5 yearsOne scale
Shared top holdingsTMED · ARKG
1.0%ADPT2.7%
0.9%PRME1.9%
0.7%IONS1.8%
0.6%FRNM0.9%
Held in common3.5%
End-of-day Nov 9, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two